Plant-Mediated Synthesis of Nanostructures for Biomedical Applications

Dear Colleagues,

The escalating prevalence of multi-drug resistant pathogens and complex chronic illnesses presents a critical challenge to global healthcare, driving the urgent need for innovative therapeutic interventions. Nanomedicine has emerged as a groundbreaking frontier, offering targeted solutions that conventional treatments cannot match. However, traditional chemical and physical methods of nanomaterial synthesis often rely on toxic reagents and high energy consumption, posing environmental and biocompatibility concerns. To address these limitations, green synthesis has pioneered a sustainable paradigm shift. This Special Issue focuses on the Plant-Mediated Synthesis of Nanostructures for Biomedical Applications, highlighting the utilization of plant extracts as eco-friendly, cost-effective, and efficient reducing and capping agents. By leveraging bioactive phytochemicals, such as polyphenols, flavonoids, and terpenoids, this biogenic approach fabricates nanostructures with minimized toxicity and enhanced biological affinity. We invite experts to contribute original research and comprehensive review articles elucidating the synthesis, characterization, and multifaceted biomedical evaluation of these green nanostructures. Key topics include, but are not limited to, their applications in targeted drug delivery, antimicrobial and antiviral therapies, oncology, tissue engineering, and biosensing. Together, we aim to map future directions for translating plant-derived nanotechnology into safe, next-generation clinical therapies. We look forward to your valuable contributions. 

Dr. Irina Macovei
Dr. Andreia Corciova
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.